Home Featured Page 174

Featured

Latest

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of Integration

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots Phase 3

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA Funds Psychedelic Therapy for Veterans; AbbVie Paid $900M Upfront for Psychedelic Candidate

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

Cybin Announces Initiation of Kernel Flow® Feasibility Study Measuring Psychedelic Effects...

Mydecine Innovations Group Announces Closing of First Tranche Under Share Subscription...

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical...

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial...

Albert Labs Files US Provisional Patent Application and Proves Out Consistent...

PT305 – Emma Farrell – Plant Spirits, Entities, and Remembering Lost...

MindMed Reports Full Year 2021 Financial Results and Business Highlights

MindMed Announces Transition of CFO

Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study

1...173174175...301 Page 174 of 301

EDITOR PICKS

Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of...

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.